BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29

• 

  Press Releases

  2025 Chikungunya Outbreak: A Global Health Challenge

  August 14, 2025

   · 

  7 min read
• 

  Editorial

  RFK Jr. Creates More Vaccine Misinformation With mRNA Cancellations

  The HHS secretary recently canceled $500 million worth of BARDA contracts around mRNA vaccine research. But the U.S. government has already spent billions on this work, which has saved millions of lives.

  August 14, 2025

   · 

  4 min read

   · 

  Dan Samorodnitsky
• 

  Pipeline

  Schrödinger Cans Early-Stage Blood Cancer Drug After Two Patient Deaths

  After two patients who received the investigational CDC7 blocker died, pushing forward with SGR-2921’s development would be “difficult,” according to Schrödinger, whose stock dropped 17.5% before the opening bell on Thursday.

  August 14, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  Entero Therapeutics, Inc. Announces Reverse Stock Split

  August 14, 2025

   · 

  4 min read
• Press Releases

  PharmaTher Founder and CEO Issues Letter to Shareholders Following the FDA Approval of Ketamine (KETARx(TM))

  August 14, 2025

   · 

  6 min read
• 

  Layoffs

  WARN Act 101: How It Actually Works

  WARN notices provide a heads up that staff will soon be unemployed, but the act that mandates them has some nuances. An attorney explains how the law works, common misconceptions about it and how it helps those about to lose their jobs.

  August 14, 2025

   · 

  5 min read

   · 

  Angela Gabriel
• Press Releases

  Hemostemix’s Expands its Marketing Team Focused on Sales in Florida

  August 14, 2025

   · 

  9 min read
• 

  Obesity

  Eli Lilly Keeps Obesity Pipeline Fresh With $1.3B Superluminal Partnership

  The Boston-based AI/ML startup focuses on endocrine and cardiometabolic diseases and will use that expertise to generate new small molecule obesity medications for Lilly.

  August 14, 2025

   · 

  1 min read

   · 

  Dan Samorodnitsky
• 

  Drug pricing

  Lilly Aims To Raise Europe Drug Prices in Response to Trumps’ Most Favored Nation Policy

  As Trump has pressured drugmakers to lower the cost of medicines in the U.S., the pharma industry has coalesced behind a message of rebalancing what nations pay to better reflect the innovation and value of drugmaking.

  August 14, 2025

   · 

  3 min read

   · 

  Annalee Armstrong
• Press Releases

  Phio Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update

  Clinical trial advances for INSTASYL siRNA lead product candidate PH-762 5th cohort enrolling patients in on-going clinical study

  August 14, 2025

   · 

  8 min read